Eupraxia Pharmaceuticals (EPRX) Other financing activities (as filed) (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted Other financing activities (as filed) of -$82,004 for Q2 2026, compared with -$21,117 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Other financing activities (as filed) (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Other financing activities (as filed) at Eupraxia Pharmaceuticals was -$165,970; for FY2025, it was -$83,671.
- In prior years, Eupraxia Pharmaceuticals' Other financing activities (as filed) was -$65,739 in FY2024, -$64,996 in FY2023 and -$67,423 in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Other financing activities (as filed) in data going back to Q1 2023.
- According to Business Quant data, Other financing activities (as filed) for the three prior quarters was -$41,783 (Q1 2026), -$20,957 (Q4 2025) and -$21,226 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -101,729.00 |
| Jun 30, 2026 | -82,004.00 |
| Mar 31, 2026 | -41,783.00 |
| Dec 31, 2025 | -20,957.00 |
| Sep 30, 2025 | -21,226.00 |
| Jun 30, 2025 | -21,117.00 |
| Mar 31, 2025 | -20,371.00 |
| Dec 31, 2024 | -17,385.00 |
| Sep 30, 2024 | -16,063.00 |
| Jun 30, 2024 | -16,022.00 |
| Mar 31, 2024 | -16,269.00 |
| Dec 31, 2023 | -16,104.00 |
| Sep 30, 2023 | -16,348.00 |
| Jun 30, 2023 | -16,324.00 |
| Mar 31, 2023 | -16,220.00 |
API Access
Eupraxia Pharmaceuticals Other financing activities (as filed) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();